Draft of Russian Clinical Practice Guidelines «Male hypogonadism»

Hypogonadism in males, defined as a decrease in serum testosterone levels in combination with characteristic symptoms and/or signs, can be observed with pathological changes in the testicles and/or pituitary gland, such as Klinefelter’s syndrome, Kallman’s syndrome, as well as in men with metabolic...

Full description

Bibliographic Details
Published in:	Ожирение и метаболизм
Main Authors:	I. I. Dedov, N. G. Mokrysheva, G. A. Melnichenko, R. V. Rozhivanov, A. A. Kamalov, А. M. Mkrtumyan, Yu. Sh. Khalimov, N. V. Vorokhobina
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2022-02-01
Subjects:	hypogonadism men testosterone deficiency testosterone clinical practice guidelines
Online Access:	https://www.omet-endojournals.ru/jour/article/view/12817

Similar Items

Guidelines for the Diagnosis and Treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus
by: Ivan I. Dedov, et al.
Published: (2017-12-01)

The prevalence of hypogonadism in men with type 2 diabetes mellitus in clinical practice
by: Galina A. Melnichenko, et al.
Published: (2019-06-01)

The clinical and epidemiological characteristics of hypogonadism in men with type 2 diabetes mellitus
by: Galina A. Mel'nichenko, et al.
Published: (2019-12-01)

The incidence and aggravating factors of male hypogonadism in type 2 diabetes
by: R. V. Rozhivanov, et al.
Published: (2022-10-01)

The frequency and peculiarities of hypogonadism in men with obesity
by: R. V. Rozhivanov, et al.
Published: (2025-05-01)

Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus (Draft)
by: Galina Afanas'evna Melnichenko, et al.
Published: (2017-06-01)

Clinical and epidemiological characteristics of male hypogonadism in type 2 diabetes in Russia: combined analysis of study data for the period 2005–2022
by: M. O. Chernova, et al.
Published: (2023-02-01)

Association between hypogonadism and reproductive tissue steroid-producing cells antibody in men with positive MAR test IgG and diabetes mellitus type 1
by: Roman V. Rozhivanov, et al.
Published: (2019-12-01)

Evaluation of the effect of testosterone replacement therapy with a transdermal testosterone on glycemic control in men with type 2 diabetes mellitus
by: R. V. Rozhivanov, et al.
Published: (2024-05-01)

The use of recombinant FSH in combination therapy in a young male with idiopathic hypogonadotropic hypogonadism
by: Yu. L. Skorodok, et al.
Published: (2018-10-01)

The role of anti-aging approaches in managing hypogonadism in sedentary older males
by: Khaled A. Abdel-Sater
Published: (2024-11-01)

Clomiphene citrate treatment outcomes in Taiwanese hypogonadal men: A single-center preliminary report
by: Jiun-Siang Tan, et al.
Published: (2017-03-01)

Hypogonadism in men with inflammatory joint diseases: Frequency and clinical characteristics
by: Taras S. Panevin, et al.
Published: (2024-06-01)

Syndrome of hypogonadism in males
Published: (2014-06-01)

Depression in men with testosterone deficiency (Preliminary results of the study)
by: Y. Osadshiy, et al.
Published: (2022-06-01)

Safety Aspects and Rational Use of Testosterone Undecanoate in the Treatment of Testosterone Deficiency: Clinical Insights
by: Campbell K, et al.
Published: (2023-03-01)

Clinical and instrumental characteristics of psoriatic arthritis in men depending on testosterone levels
by: T. S. Panevin, et al.
Published: (2024-12-01)

Current National and International Guidelines for the Management of Male Hypogonadism: Helping Clinicians to Navigate Variation in Diagnostic Criteria and Treatment Recommendations
by: Ahmed Al-Sharefi, et al.
Published: (2020-09-01)

Testosterone and aging male, a perspective from a developing country
by: Bac Nguyen Hoai, et al.
Published: (2023-12-01)

Hypogonadism syndrome in men with inflammatory joint diseases: A review
by: Taras S. Panevin, et al.
Published: (2023-07-01)

Clinical and pharmacological basis of the use of testosterone drugs for hormonal replacement therapy for hypogonadism in men
by: N. I. Volkova, et al.
Published: (2022-09-01)

High C-reactive protein is associated with increased risk of biochemical hypogonadism: a population-based cohort study
by: Amar Osmancevic, et al.
Published: (2022-06-01)

Usefulness of routine assessment of free testosterone for the diagnosis of functional male hypogonadism
by: Paolo Facondo, et al.
Published: (2022-12-01)

The complex relation between obstructive sleep apnoea syndrome, hypogonadism and testosterone replacement therapy
by: Andrea Graziani, et al.
Published: (2023-10-01)

Editorial: Aging and male hypogonadism
by: Kai Xia, et al.
Published: (2023-05-01)

The association of hypogonadism with depression and its treatments
by: Rita Indirli, et al.
Published: (2023-08-01)

The role of hypogonadism correction in metabolic syndrome treatment in men: clinical case report
Published: (2009-06-01)

Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
Published: (2013-03-01)

Age-specific testosterone thresholds: reconsidering diagnostic criteria for hypogonadism across generations of Vietnamese men
by: Bac Nguyen Hoai, et al.
Published: (2024-12-01)

Adult Male Hypogonadism: A Laboratory Medicine Perspective on Its Diagnosis and Management
by: Mark Livingston, et al.
Published: (2023-12-01)

Plasma metabolomics in male primary and functional hypogonadism
by: Giuseppe Grande, et al.
Published: (2023-05-01)

Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
Published: (2012-12-01)

Impact of testosterone levels and testosterone replacement ther-apy on men’s health
by: Zuzanna Karbowska, et al.
Published: (2023-12-01)

Relationship between Varicocele and Male Hypogonadism: A Review with Meta-Analysis
by: Giorgio Ivan Russo, et al.
Published: (2022-03-01)

Management of Male Fertility in Hypogonadal Patients on Testosterone Replacement Therapy
by: Julius Fink, et al.
Published: (2024-02-01)

Acquired Male Hypogonadism in the Post-Genomic Era—A Narrative Review
by: Giuseppe Grande, et al.
Published: (2023-09-01)

The HEAT-Registry (HEmatopoietic Affection by Testosterone): comparison of a transdermal gel vs long-acting intramuscular testosterone undecanoate in hypogonadal men
by: Michael Zitzmann, et al.
Published: (2022-12-01)

New opportunities for the correction of non-alcoholic fatty liver disease in men with type 2 diabetes mellitus and hypogonadism
by: Irina A. Khripun, et al.
Published: (2020-12-01)

Hypogonadism Prevalence and Correlation with Aging Male Symptoms and International Index of Erectile Function Scores
by: Bahadır Şahin, et al.
Published: (2024-03-01)

A study to evaluate the prevalence of hypogonadism in Indian males with Type-2 diabetes mellitus
by: Pankaj Kumar Agarwal, et al.
Published: (2017-01-01)